Today news
The same in other media
Long-acting injectable drug prevents HIV infections
Reading now: 845
A recruitment ad for the clinical trial that found an injectable long-acting drug could protect certain groups from HIV infection.
By Jon CohenIt’s not an AIDS vaccine but it may be the closest thing to one so far. A long-acting antiretroviral drug given as an injection every two months powerfully protected uninfected people from HIV in a large-scale study that was disrupted by the COVID-19 pandemic.
The apparent success—the study has not been published in a peer-reviewed journal or presented to HIV researchers at a meeting—offers a potentially easier alternative to taking daily pills of other antiretrovirals, which has proven difficult for many people.The strategy of uninfected people taking drugs to ward off HIV, known as pre-exposure
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
COVID-19
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|